Cefotaxime
Cefotaxime is an inhibitor of penicillin binding protein. (In Vitro) :Cefotaxime exhibits an MIC of 0.0625 mg/L for V. vulnificus CMCP6. (In Vivo) :The combination of ciprofloxacin and cefotaxime is more effective in clearing V. vulnificus in vivo than previously used regimens.
Product Specifications
CAS Number
63527-52-6
Field of Research
Pharmacology & Drug Discovery
Purity
>98% (HPLC)
Solubility
DMSO:91 mg/mL (199.79 mM)
Smiles
CO/N=C (\C (=O) N[C@@H]1C (=O) N2C (C (=O) O) =C (COC (C) =O) CS[C@H]12) c1csc (N) n1
Molecular Formula
C16H17N5O7S2
Molecular Weight
455.46
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
(6R7R) -3- (acetoxymethyl) -7- ((Z) -2- (2-aminothiazol-4-yl) -2- (methoxyimino) acetamido) -8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb2926047-01 20 µg
Recombinant Staphylococcus aureus Probable quinol oxidase subunit 2 (qoxA)
Sign In for Pricing
View Details orb2926047-02 100 µg
Recombinant Staphylococcus aureus Probable quinol oxidase subunit 2 (qoxA)
Sign In for Pricing
View Details 
